Vimarsana
Biggest News Aggregation in the World

Page 5 - Cm Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Life Sciences Today - Breaking & Trending Today

Sema4 (NASDAQ:SMFR) Rating Lowered to Hold at Zacks Investment Research - Vimarsana News

Sema4 (NASDAQ:SMFR) Rating Lowered to Hold at Zacks Investment Research

Sema4 (NASDAQ:SMFR – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Tuesday, Zacks.com reports. According to Zacks, “Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and […]

Stock Analysts' Downgrades for May 24th (AB, ACSAY, AROW, BVN, CAAS, CIB, CLS, COHR, DVN, GRPTF) - Vimarsana News

Stock Analysts' Downgrades for May 24th (AB, ACSAY, AROW, BVN, CAAS, CIB, CLS, COHR, DVN, GRPTF)

Stock Analysts’ downgrades for Tuesday, May 24th: AllianceBernstein (NYSE:AB) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “ALLIANCE CAP MANAGEMENT L.P. provides diversified investment management services, primarily to pension funds, endowments, foreign financial institutions, and to individual investors. “ ACS, Actividades de Construcción y […]

EQRx (NASDAQ:EQRX) Downgraded by Zacks Investment Research to Sell - Vimarsana News

EQRx (NASDAQ:EQRX) Downgraded by Zacks Investment Research to Sell

Zacks Investment Research cut shares of EQRx (NASDAQ:EQRX – Get Rating) from a hold rating to a sell rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “EQRx Inc. is a pharmaceutical company is involved in developing and delivering medicines to patients. EQRx Inc., formerly known as CM Life Sciences III, is […]

Sema4 (NASDAQ:SMFR) Lifted to "Hold" at Zacks Investment Research - Vimarsana News

Sema4 (NASDAQ:SMFR) Lifted to "Hold" at Zacks Investment Research

Sema4 (NASDAQ:SMFR – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic […]

Analysts' Downgrades for May 10th (AFRM, ARCH, BCC, BG, BHF, BIIB, DBSDY, DIISY, DLG, E) - Vimarsana News

Analysts' Downgrades for May 10th (AFRM, ARCH, BCC, BG, BHF, BIIB, DBSDY, DIISY, DLG, E)

Analysts’ downgrades for Tuesday, May 10th: Affirm (NASDAQ:AFRM) was downgraded by analysts at Stephens from an equal weight rating to an underweight rating. Stephens currently has $17.00 target price on the stock, down from their previous target price of $51.00. Arch Resources (NYSE:ARCH) was downgraded by analysts at Zacks Investment Research from a strong-buy rating […]